Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multifactorial Inheritance | 3 | 2015 | 22 | 1.320 |
Why?
|
| Body Height | 4 | 2015 | 75 | 1.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 67 | 0.830 |
Why?
|
| Genome-Wide Association Study | 5 | 2015 | 326 | 0.810 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 137 | 0.770 |
Why?
|
| Phenotype | 7 | 2023 | 1145 | 0.760 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 63 | 0.580 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 262 | 0.570 |
Why?
|
| Tissue Donors | 1 | 2018 | 134 | 0.570 |
Why?
|
| Organoids | 3 | 2024 | 41 | 0.490 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 552 | 0.480 |
Why?
|
| Genetic Vectors | 1 | 2021 | 818 | 0.470 |
Why?
|
| Dependovirus | 1 | 2021 | 659 | 0.460 |
Why?
|
| CRISPR-Cas Systems | 4 | 2023 | 332 | 0.460 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 84 | 0.410 |
Why?
|
| Crohn Disease | 1 | 2014 | 113 | 0.400 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 457 | 0.370 |
Why?
|
| Alleles | 1 | 2011 | 417 | 0.350 |
Why?
|
| Algorithms | 3 | 2023 | 1006 | 0.340 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 560 | 0.310 |
Why?
|
| Genome, Human | 3 | 2018 | 221 | 0.280 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 181 | 0.260 |
Why?
|
| Brain | 2 | 2024 | 1485 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2018 | 367 | 0.250 |
Why?
|
| Vagus Nerve | 1 | 2024 | 23 | 0.240 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2017 | 27 | 0.240 |
Why?
|
| Immunoglobulins | 1 | 2024 | 76 | 0.240 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 89 | 0.220 |
Why?
|
| Hyaluronan Receptors | 2 | 2015 | 35 | 0.220 |
Why?
|
| Herpesvirus 1, Human | 1 | 2024 | 78 | 0.220 |
Why?
|
| Genes, Immunoglobulin | 1 | 2023 | 32 | 0.220 |
Why?
|
| Databases, Genetic | 2 | 2017 | 85 | 0.220 |
Why?
|
| Antigens, CD | 1 | 2024 | 343 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 450 | 0.200 |
Why?
|
| Thioctic Acid | 1 | 2022 | 7 | 0.200 |
Why?
|
| Hibiscus | 1 | 2022 | 2 | 0.200 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 21 | 0.190 |
Why?
|
| Microglia | 1 | 2024 | 229 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 667 | 0.190 |
Why?
|
| Humans | 20 | 2024 | 60081 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2017 | 2480 | 0.170 |
Why?
|
| Mitochondria | 1 | 2023 | 338 | 0.170 |
Why?
|
| Swine | 1 | 2021 | 349 | 0.170 |
Why?
|
| Systems Biology | 2 | 2010 | 28 | 0.170 |
Why?
|
| Databases, Protein | 2 | 2010 | 47 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2022 | 168 | 0.170 |
Why?
|
| Intellectual Disability | 1 | 2022 | 164 | 0.160 |
Why?
|
| Data Mining | 2 | 2010 | 47 | 0.160 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 209 | 0.160 |
Why?
|
| Cell Line | 1 | 2023 | 2008 | 0.160 |
Why?
|
| Gene Editing | 1 | 2023 | 301 | 0.150 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 307 | 0.150 |
Why?
|
| DNA, Fungal | 1 | 2018 | 58 | 0.150 |
Why?
|
| Sample Size | 1 | 2018 | 59 | 0.150 |
Why?
|
| Gene Library | 1 | 2018 | 99 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 677 | 0.140 |
Why?
|
| Geography | 1 | 2017 | 32 | 0.140 |
Why?
|
| Disease | 1 | 2017 | 26 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2017 | 178 | 0.130 |
Why?
|
| Obesity | 2 | 2014 | 1191 | 0.130 |
Why?
|
| Point Mutation | 2 | 2018 | 161 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2018 | 379 | 0.130 |
Why?
|
| F-Box Proteins | 1 | 2015 | 15 | 0.130 |
Why?
|
| Gene Frequency | 2 | 2014 | 129 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2018 | 461 | 0.120 |
Why?
|
| Leg Bones | 1 | 2015 | 2 | 0.120 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 33 | 0.120 |
Why?
|
| Homozygote | 1 | 2015 | 115 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2014 | 774 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2015 | 107 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2021 | 766 | 0.120 |
Why?
|
| Group II Chaperonins | 1 | 2014 | 2 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 677 | 0.120 |
Why?
|
| Female | 8 | 2024 | 31226 | 0.120 |
Why?
|
| Genes, Recessive | 1 | 2014 | 50 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 184 | 0.110 |
Why?
|
| Male | 6 | 2024 | 27951 | 0.110 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 283 | 0.110 |
Why?
|
| Proteins | 2 | 2010 | 738 | 0.110 |
Why?
|
| Albuminuria | 1 | 2014 | 24 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2021 | 742 | 0.110 |
Why?
|
| Mice | 4 | 2022 | 10317 | 0.110 |
Why?
|
| Diabetic Nephropathies | 1 | 2014 | 35 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2014 | 255 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 534 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 376 | 0.110 |
Why?
|
| Growth Plate | 1 | 2012 | 14 | 0.100 |
Why?
|
| Animals | 7 | 2022 | 19739 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 309 | 0.100 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2012 | 3 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 193 | 0.100 |
Why?
|
| Response Elements | 1 | 2012 | 43 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2012 | 14 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 38 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 59 | 0.100 |
Why?
|
| Siblings | 1 | 2011 | 45 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1542 | 0.090 |
Why?
|
| Cognition | 1 | 2015 | 466 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 117 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 110 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 628 | 0.090 |
Why?
|
| Transcriptome | 2 | 2024 | 337 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 203 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 278 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 83 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 71 | 0.080 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 74 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2615 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 713 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2012 | 605 | 0.080 |
Why?
|
| Base Sequence | 2 | 2023 | 1301 | 0.080 |
Why?
|
| Adult | 3 | 2015 | 15972 | 0.070 |
Why?
|
| Middle Aged | 3 | 2015 | 16542 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 845 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2006 | 53 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2014 | 770 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2024 | 48 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 70 | 0.060 |
Why?
|
| Software | 3 | 2015 | 376 | 0.060 |
Why?
|
| United States | 1 | 2017 | 7622 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2024 | 271 | 0.050 |
Why?
|
| Aged | 2 | 2024 | 13596 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 223 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 78 | 0.050 |
Why?
|
| Stem Cells | 1 | 2024 | 258 | 0.050 |
Why?
|
| Chromosome Disorders | 1 | 2022 | 13 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2022 | 26 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2022 | 41 | 0.050 |
Why?
|
| Neoplasms | 1 | 2012 | 1262 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 95 | 0.050 |
Why?
|
| Iron | 1 | 2022 | 139 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 157 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2023 | 638 | 0.050 |
Why?
|
| Adolescent | 1 | 2011 | 5944 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2022 | 163 | 0.040 |
Why?
|
| Systems Integration | 2 | 2010 | 27 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 248 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2024 | 604 | 0.040 |
Why?
|
| Terminology as Topic | 2 | 2010 | 138 | 0.040 |
Why?
|
| Genes, Synthetic | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mutation | 2 | 2023 | 2466 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2018 | 81 | 0.040 |
Why?
|
| Biotechnology | 1 | 2018 | 42 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2018 | 114 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 170 | 0.040 |
Why?
|
| Mosaicism | 1 | 2017 | 26 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 45 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 496 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 585 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 337 | 0.030 |
Why?
|
| Internet | 2 | 2010 | 465 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2015 | 5 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2015 | 66 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 2015 | 15 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 65 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 83 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 85 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 124 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 105 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 150 | 0.030 |
Why?
|
| Chaperonins | 1 | 2014 | 8 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 19 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 5200 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2014 | 73 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 137 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2015 | 113 | 0.030 |
Why?
|
| Educational Status | 1 | 2015 | 273 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 424 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 673 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 860 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 522 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 71 | 0.020 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 5 | 0.020 |
Why?
|
| Filamins | 1 | 2012 | 7 | 0.020 |
Why?
|
| RNA Interference | 1 | 2015 | 592 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 54 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 58 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2012 | 99 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 66 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 106 | 0.020 |
Why?
|
| Zebrafish | 1 | 2014 | 323 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 184 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2012 | 92 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 193 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2012 | 95 | 0.020 |
Why?
|
| Seizures | 1 | 2012 | 118 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 190 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1571 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 492 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 666 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 337 | 0.020 |
Why?
|
| Genomics | 1 | 2012 | 317 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2010 | 119 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 154 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3621 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1565 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 1315 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 802 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1522 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 2361 | 0.010 |
Why?
|